Characterization of the effects of oxytocin on fear recognition in patients with schizophrenia and in healthy controls.
about
Oxytocin in the socioemotional brain: implications for psychiatric disordersSex and diagnosis specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disorders.Potential of Oxytocin in the Treatment of SchizophreniaReduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders.Oxytocin administration enhances controlled social cognition in patients with schizophreniaAssociation between Genetic Variation in the Oxytocin Receptor Gene and Emotional Withdrawal, but not between Oxytocin Pathway Genes and Diagnosis in Psychotic Disorders.Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia.Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia.Oxytocin and social cognition in affective and psychotic disorders.Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trials.Effects of Oxytocin on Neural Response to Facial Expressions in Patients with Schizophrenia.Frontiers in oxytocin science: from basic to practice.Brain circuit dysfunction in a distinct subset of chronic psychotic patients.Oxytocin, testosterone, and human social cognition.Oxytocin and Social Cognitions in Schizophrenia: A Systematic Review.First experiences with neuropsychological effects of oxytocin administration in childhood-onset craniopharyngioma.
P2860
Q28079176-C35E63CA-EEF2-46C2-89BF-0E57D74DC039Q30277149-49643120-2C53-4E24-852F-5ECB6EF77490Q33761384-AB9D7523-E97A-45DA-8C14-8CBF1F792721Q34322999-82B2FD1A-D2CE-498C-B3FE-938AD9C5188DQ34790823-7A423D63-680C-4508-AAF0-9C181C73C1A0Q35003945-5F7F1FA7-8458-4B33-B387-74BCB156A2BBQ35116515-006B9187-E2D1-44C2-BDD4-120F05F832FAQ35117441-AB446AC1-FC39-4C13-9D52-D7C13A873998Q35646296-ECA41A20-7B27-4469-9715-A8A8C3966D2FQ35754102-264F6017-1D18-4B9B-8B34-51CE5E9E302AQ36821775-6113B555-5956-49FE-8519-46AED50970AAQ37408508-EFB93442-94B9-458C-A102-26B8E7AE44A5Q38226241-F7F6A39D-B3EA-402B-B484-DBEC8F19203FQ38336027-02A44461-DFCA-4784-8CBD-1BCAE5DD4EB7Q38675134-8E3AEF74-DD3C-419C-B0D7-E48D2F0F830BQ47342329-D254591C-DA2D-4A7F-8A86-7E0797BA7358
P2860
Characterization of the effects of oxytocin on fear recognition in patients with schizophrenia and in healthy controls.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization of the effect ...... renia and in healthy controls.
@en
Characterization of the effect ...... renia and in healthy controls.
@nl
type
label
Characterization of the effect ...... renia and in healthy controls.
@en
Characterization of the effect ...... renia and in healthy controls.
@nl
prefLabel
Characterization of the effect ...... renia and in healthy controls.
@en
Characterization of the effect ...... renia and in healthy controls.
@nl
P2093
P2860
P921
P356
P1476
Characterization of the effect ...... renia and in healthy controls.
@en
P2093
Meytal Fischer-Shofty
Simone G Shamay-Tsoory
Yechiel Levkovitz
P2860
P356
10.3389/FNINS.2013.00127
P577
2013-07-18T00:00:00Z